Carregant...
MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
BACKGROUND: Recent evidence indicated that the aberrant expression of microRNA plays a crucial role in the development of cervical cancer. The overall shorter survival was strongly related to the abnormal expression of microRNA-34a (miR-34a) and microRNA-206 (miR-206), which target B cell lymphoma-2...
Guardat en:
| Publicat a: | Cancer Cell Int |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5466768/ https://ncbi.nlm.nih.gov/pubmed/28615991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-017-0431-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|